Cargando…

Enhancing Intermediate Vision in Patients Affected by Epiretinal Membrane Treated by Phaco-Vitrectomy

Background: The aim of this research was to see if a refractive enhanced monofocal IOL (Eyhance IOL, IOL Abbott Medical Optics, Inc., Santa Ana, CA, USA) can provide better intermediate vision in patients undergoing phaco-vitrectomy due to cataract and epiretinal macular membrane (ERM). Methods: A n...

Descripción completa

Detalles Bibliográficos
Autores principales: Giansanti, Fabrizio, Dragotto, Francesco, Nicolosi, Cristina, Alonzo, Ludovica, Cifarelli, Lorenzo, Franco, Fabrizio Gaetano Saverio, Vannozzi, Lorenzo, Abbruzzese, Giacomo, Bacherini, Daniela, Virgili, Gianni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420151/
https://www.ncbi.nlm.nih.gov/pubmed/37568418
http://dx.doi.org/10.3390/jcm12155016
_version_ 1785088706348056576
author Giansanti, Fabrizio
Dragotto, Francesco
Nicolosi, Cristina
Alonzo, Ludovica
Cifarelli, Lorenzo
Franco, Fabrizio Gaetano Saverio
Vannozzi, Lorenzo
Abbruzzese, Giacomo
Bacherini, Daniela
Virgili, Gianni
author_facet Giansanti, Fabrizio
Dragotto, Francesco
Nicolosi, Cristina
Alonzo, Ludovica
Cifarelli, Lorenzo
Franco, Fabrizio Gaetano Saverio
Vannozzi, Lorenzo
Abbruzzese, Giacomo
Bacherini, Daniela
Virgili, Gianni
author_sort Giansanti, Fabrizio
collection PubMed
description Background: The aim of this research was to see if a refractive enhanced monofocal IOL (Eyhance IOL, IOL Abbott Medical Optics, Inc., Santa Ana, CA, USA) can provide better intermediate vision in patients undergoing phaco-vitrectomy due to cataract and epiretinal macular membrane (ERM). Methods: A nonrandomized prospective observational comparative study enrolled patients affected by cataract and ERM undergoing phaco-vitrectomy. A follow up of 6 months was established. Corrected and uncorrected visual acuity of both monocular and binocular types were assessed regarding intermediate and far distances. The CATQUEST 9-SF questionnaire was administered preoperatively and at the last follow-up. Results: Twenty-three eyes of twenty-three patients were enrolled, with 11 in the enhanced monofocal group. The uncorrected and corrected distance visual acuity after 6 months was not statistically different. Both monocular and binocular uncorrected intermediate visual acuity after 6 months were higher in the enhanced monofocal group (p < 0.001). The corrected intermediate visual acuity after 6 months was higher in the enhanced monofocal group (p = 0.01). The CATQUEST-9SF questionnaire showed significant differences in the variation between the preoperative condition and six-month postoperative results (p < 0.001). Conclusions: This refractive enhanced monofocal IOL can provide better intermediate vision compared to a standard monofocal IOL in patients undergoing phaco-vitrectomy due to cataracts and ERM. Further studies are necessary to confirm these results.
format Online
Article
Text
id pubmed-10420151
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104201512023-08-12 Enhancing Intermediate Vision in Patients Affected by Epiretinal Membrane Treated by Phaco-Vitrectomy Giansanti, Fabrizio Dragotto, Francesco Nicolosi, Cristina Alonzo, Ludovica Cifarelli, Lorenzo Franco, Fabrizio Gaetano Saverio Vannozzi, Lorenzo Abbruzzese, Giacomo Bacherini, Daniela Virgili, Gianni J Clin Med Article Background: The aim of this research was to see if a refractive enhanced monofocal IOL (Eyhance IOL, IOL Abbott Medical Optics, Inc., Santa Ana, CA, USA) can provide better intermediate vision in patients undergoing phaco-vitrectomy due to cataract and epiretinal macular membrane (ERM). Methods: A nonrandomized prospective observational comparative study enrolled patients affected by cataract and ERM undergoing phaco-vitrectomy. A follow up of 6 months was established. Corrected and uncorrected visual acuity of both monocular and binocular types were assessed regarding intermediate and far distances. The CATQUEST 9-SF questionnaire was administered preoperatively and at the last follow-up. Results: Twenty-three eyes of twenty-three patients were enrolled, with 11 in the enhanced monofocal group. The uncorrected and corrected distance visual acuity after 6 months was not statistically different. Both monocular and binocular uncorrected intermediate visual acuity after 6 months were higher in the enhanced monofocal group (p < 0.001). The corrected intermediate visual acuity after 6 months was higher in the enhanced monofocal group (p = 0.01). The CATQUEST-9SF questionnaire showed significant differences in the variation between the preoperative condition and six-month postoperative results (p < 0.001). Conclusions: This refractive enhanced monofocal IOL can provide better intermediate vision compared to a standard monofocal IOL in patients undergoing phaco-vitrectomy due to cataracts and ERM. Further studies are necessary to confirm these results. MDPI 2023-07-30 /pmc/articles/PMC10420151/ /pubmed/37568418 http://dx.doi.org/10.3390/jcm12155016 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Giansanti, Fabrizio
Dragotto, Francesco
Nicolosi, Cristina
Alonzo, Ludovica
Cifarelli, Lorenzo
Franco, Fabrizio Gaetano Saverio
Vannozzi, Lorenzo
Abbruzzese, Giacomo
Bacherini, Daniela
Virgili, Gianni
Enhancing Intermediate Vision in Patients Affected by Epiretinal Membrane Treated by Phaco-Vitrectomy
title Enhancing Intermediate Vision in Patients Affected by Epiretinal Membrane Treated by Phaco-Vitrectomy
title_full Enhancing Intermediate Vision in Patients Affected by Epiretinal Membrane Treated by Phaco-Vitrectomy
title_fullStr Enhancing Intermediate Vision in Patients Affected by Epiretinal Membrane Treated by Phaco-Vitrectomy
title_full_unstemmed Enhancing Intermediate Vision in Patients Affected by Epiretinal Membrane Treated by Phaco-Vitrectomy
title_short Enhancing Intermediate Vision in Patients Affected by Epiretinal Membrane Treated by Phaco-Vitrectomy
title_sort enhancing intermediate vision in patients affected by epiretinal membrane treated by phaco-vitrectomy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420151/
https://www.ncbi.nlm.nih.gov/pubmed/37568418
http://dx.doi.org/10.3390/jcm12155016
work_keys_str_mv AT giansantifabrizio enhancingintermediatevisioninpatientsaffectedbyepiretinalmembranetreatedbyphacovitrectomy
AT dragottofrancesco enhancingintermediatevisioninpatientsaffectedbyepiretinalmembranetreatedbyphacovitrectomy
AT nicolosicristina enhancingintermediatevisioninpatientsaffectedbyepiretinalmembranetreatedbyphacovitrectomy
AT alonzoludovica enhancingintermediatevisioninpatientsaffectedbyepiretinalmembranetreatedbyphacovitrectomy
AT cifarellilorenzo enhancingintermediatevisioninpatientsaffectedbyepiretinalmembranetreatedbyphacovitrectomy
AT francofabriziogaetanosaverio enhancingintermediatevisioninpatientsaffectedbyepiretinalmembranetreatedbyphacovitrectomy
AT vannozzilorenzo enhancingintermediatevisioninpatientsaffectedbyepiretinalmembranetreatedbyphacovitrectomy
AT abbruzzesegiacomo enhancingintermediatevisioninpatientsaffectedbyepiretinalmembranetreatedbyphacovitrectomy
AT bacherinidaniela enhancingintermediatevisioninpatientsaffectedbyepiretinalmembranetreatedbyphacovitrectomy
AT virgiligianni enhancingintermediatevisioninpatientsaffectedbyepiretinalmembranetreatedbyphacovitrectomy